UROPLASTY RECEIVES APPROVABLE LETTER FROM FDA FOR MACROPLASTIQUE IMPLANTS

Wednesday afternoon, Uroplasty, Inc., medical devices company, announced that it has received an approvable letter from FDA relating to its pre-market approval application for Macroplastique Implants for the treatment of female stress urinary incontinence. Trading Markets Live (http://www.tradingmarkets.com/.site/news/BREAKING%20NEWS/397759/)